NATHAN ROBERSON: Open Payments
NPI 1023532280 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $81 |
| Lilly USA, LLC | 2 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $19 |
| Seqirus USA Inc | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: FREESTYLE LIBRE, REXULTI, MOUNJARO, WATCHMAN Access System, Wegovy, Flucelvax, PREVNAR 20, NUZYRA.
Industry payments across GA — which companies pay providers there.
